Yüklüyor......

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic

Background: Vitamin K antagonists have been the treatment of choice in preventing thromboembolic events, but problems such as frequent dose adjustment and monitoring of coagulation status, including multiple drug and food interactions, make their use difficult. Dabigatran etexilate is a new oral dir...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Donaldson M, Norbeck AO
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Centro de Investigaciones y Publicaciones Farmaceuticas 2013-06-01
Seri Bilgileri:Pharmacy Practice
Konular:
Online Erişim:http://www.pharmacypractice.org/journal/index.php/pp/article/view/340
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!